— Know what they know.
Not Investment Advice

EVIO OTC

EVIO, Inc.
1W: +0.0% 1M: -98.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±5196.4%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $959685 mcap · 10.12B float · 0.030% daily turnover · Short 23% of daily vol

Cash Flow Trends

Operating Cash Flow
-$652K -605.4% ▼
Capital Expenditures
$67K -737.5% ▼
5Y CAGR: -23.3%
Free Cash Flow
-$719K -694.2% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$7K +96.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$12M-$21M-$2M-$965K$48K
Depreciation & Amort.$725K$1M$888K$882K$461K
Stock-Based Comp.$3M$1M$1M$10K$0
Change in Working Capital$490K$2M$1M$2M$239K
Other Non-Cash Items$4M$5M-$2M-$993K-$1M
Operating Cash Flow-$4M-$3M-$2M$129K-$652K
— Investing Activities —
Capital Expenditures-$1M-$408K-$60K-$8K-$67K
Acquisitions (Net)-$3M$0$0$0$182K
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$1M$761K$80K$0$600K
Investing Cash Flow-$4M$353K$20K-$8K$715K
— Financing Activities —
Net Debt Issuance$7M$1M$245K-$737K-$73K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$157K$411K$2M$396K$0
Financing Cash Flow$9M$2M$2M-$309K-$73K
Net Change in Cash-$39K$29K$86K-$185K-$7K
Cash End of Period$82K$110K$197K$12K$5K
Free Cash Flow-$6M-$3M-$2M$121K-$719K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms